ORCID as entered in ROS

Select Publications
2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, pp. E45 - E45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000672599900120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'SUN-119 COMPARING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THREE COUNTRIES - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in Kidney International Reports, Elsevier BV, Vol. 5, pp. S250 - S250, http://dx.doi.org/10.1016/j.ekir.2020.02.646
,2019, 'Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence', in DIABETES, AMER DIABETES ASSOC, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1129-P
,2019, 'Temporal Trends in Pharmacotherapy for Diabetes', in DIABETES, AMER DIABETES ASSOC, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1130-P
,2018, 'INFECTION-RELATED HOSPITALISATIONS ACROSS DIFFERENT LEVELS OF KIDNEY FUNCTION: DATA FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 40 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'KIDNEY FUNCTION, GLUCOSE-LOWERING TREATMENT AND HBA1C LEVELS IN PEOPLE WITH PREVALENT DIABETES: A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, Vol. 23, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S23 - S23, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,